FDA Inspection 1175659 — Nancy L. Bartlett, MD

Nancy L. Bartlett, MD — FEI 3003180903

The FDA completed an inspection of Nancy L. Bartlett, MD on Jun 28, 2022 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 28, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saint Louis, MO (United States)

Additional Details

Clinical Investigator (CI)